Kåre Schultz om skamskudt Teva-aktie: »Det er rationelt nok set fra markedets synsvinkel« - FINANS
Kare Schultz | C-SPAN.org
Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
Drug maker Teva to fire 350 workers in efficiency bid for southern Israeli plant | The Times of Israel
Israeli Troubled Teva appoints Kare Schultz CEO
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Serial Problem Solver
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Serial Problem Solver
Teva Appoints Lundbeck's Schultz as CEO | Ctech
Teva boss hits out at opioid lawsuits | Financial Times
Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation former CEO Mark Alles are sworn in prior to testifying by video conference during a hearing before the US
Teva: We must lay off 14,000 workers | Companies | POST Online Media
Where is Kåre Schultz? | Ctech
Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
A Look At Kare Schultz, The New CEO In Charge Of Teva
Teva Pharmaceuticals Names Kare Schultz As New CEO | Fortune
After turbulent years, Teva CEO Schultz forecasts stability - The Jerusalem Post
Teva expands sustainability notes issue to $5b - Globes
Teva neck-deep in legal trouble with no end in sight | Ctech
Kåre Schultz forlænger med Teva: Får op til 26 mio. kr. mere i løn - FINANS
Does Teva Really Have $5 Billion In Debt Payments Due Next Year? (NYSE:TEVA) | Seeking Alpha
Ambassador views Teva CEO as important player in potential vaccine alliance
Danish Top Manager in Israeli Teva stands for key role in vaccine cooperation | News Infinitum
Troubled Teva Hires CEO with Turnaround Experience - Hamodia.com
Israel's Teva Pharm in talks to co-produce COVID-19 vaccines, CEO says